Login / Signup

Patient preferences in chronic immune-mediated inflammatory diseases potentially treated with biological drugs: discrete choice analysis using real-world data analysis.

Daniel Ginard-VicensJesús Tornero-MolinaL Fernández-Fuente-BursónM L González GómezE MorenoM SallerasM A GuiginiAdrià Burniol-GarcíaC Crespo
Published in: Expert review of pharmacoeconomics & outcomes research (2023)
Chronic IMIDs patients showed a preference toward a faster, personalized service, even with a trade-off in terms of out-of-pocket price.
Keyphrases
  • data analysis
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • healthcare
  • mental health
  • oxidative stress
  • peritoneal dialysis
  • patient reported outcomes